US 7541359B2
· Apodaca et al.
· 2009
[cited by applicant]
US 20080003673A1
· Abuin et al.
· 2008
[cited by applicant]
WO WO2007100722A2
· 2007
[cited by applicant]
WO WO2012030983A2
· 2012
[cited by applicant]
WO WO2013142571A2
· 2013
[cited by applicant]
Simmons and Michels (2015) “Type 1 diabetes: A predictable disease”, World Journal of Diabetes, 6(3): 380-90. (Year: 2015).
[cited by examiner]
Shortle (2009) “One sequence plus one mutation equals two folds”, Proceedings of the National Academy of Science, USA., 106(50): 21011-12. (Year: 2009).
[cited by examiner]
Roder, et al. (2016) “Pancreatic regulation of glucose homeostasis”, Experimental & Molecular Medicine, 48: e219, 19 pages long. (Year: 2016).
[cited by examiner]
Winzell and Ahren (2004) “The High-Fat Diet-Fed Mouse: A Model for Studying Mechanisms and Treatment of Impaired Glucose Tolerance and Type 2 Diabetes”, Diabetes, 53(S3): S215-19. (Year: 2014).
[cited by examiner]
Casal and Haskins (2006) “Large animal models and gene therapy”, European Journal of Human Genetics, 14: 266-72. (Year: 2006 ).
[cited by examiner]
Long, et al. (2016) “The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria” Cell, 166: 424-35. (Year: 2016).
[cited by examiner]
Gomez-Úriz et al., “Obesity and ischemic stroke modulate the methylation levels of KCNQ1 in white blood cells,” human molecular genetics, 24(5):1432-1440 (2015).
[cited by applicant]
Larrick et al., “Uncoupling mitochondrial respiration for diabesity,” Rejuvenation research, 19(4):337-340 (2016).
[cited by applicant]
Long et al., “The secreted enzyme PM20D1 regulates lipidated amino acid uncouplers of mitochondria,” Cell, 166(2):424-435 (2016).
[cited by applicant]
Partial European Search Report and Written Opinion received for EP Patent Application No. EP16860861 mailed Mar. 8, 2019.
[cited by applicant]
Smorlesi et al., “The adipose organ: white-brown adipocyte plasticity and metabolic inflammation,” Obesity Reviews, 13:83-96 (2012).
[cited by applicant]
Bab et al., “Skeletal Lipidomics: Regulation of Bone Metabolism by Fatty Acid Amide Family,” Brit J Pharmacol, 163(7): 1441-1446 (2011).
[cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US/16/59289 mailed Apr. 12, 2017.
[cited by applicant]
Smoum et al., “Oleoyl Serine, an Endogenous N-acyl Amide, Modulates Bone Remodeling and Mass,” P Natl Acad Sci USA, 107(41): 17710-17715 (2010).
[cited by applicant]
Wang et al., “N-Oleoyl Glycine, a Lipoamino Acid, Stimulates Adipogenesis Associated with Activation of CB1 Receptor and Akt Signaling Pathway in 3T3-L1 Adipocyte,” Biochem Bioph Res Co, 466(3): 438-443 (2015).
[cited by applicant]
Extended European Search Report and Written Opinion received for EP Patent Application No. EP16860861 mailed May 21, 2019.
[cited by applicant]
Gomez-Uriz et al., “Obesity and ischemic stroke modulate the methylation levels of KCNQ1 in white blood cells,” Human Mol Genet 24(5):1432-1440 (2014).
[cited by applicant]
Han et al., “Quantitative LC-MS/MS analysis of arachidonyl amino acids in mouse brain with treatment of FAAH inhibitor,” Analyt Biochem 432(2):74-81 (2013).
[cited by applicant]
Hanus et al., “N-Acyl amino acids and their impact on biological processes: N-acyl amino acids,” Biofact 40(4):381-388 (2014).
[cited by applicant]
Huang et al., “Identification of a new class of molecules the arachidonyl amino acids, and characterization of one member that inhibits pain,” J Bio Chem 276(46):42639-42644 (2001).
[cited by applicant]
Ikeda et al., “Identification of N-arachidonylglycine, U18666A, and 4-androstene-3,17-dione as novel insulin Secretagogues,” Biochem Biophys Res Comm 333(3):778-786 (2005).
[cited by applicant]
Connor et al., “N-Acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets”, British journal of pharmacology 160(8): 1857-1871 (2010).
[cited by applicant]